Next Article in Journal
The Roles of YAP/TAZ and the Hippo Pathway in Healthy and Diseased Skin
Next Article in Special Issue
Systematic Review of Patient-Derived Xenograft Models for Preclinical Studies of Anti-Cancer Drugs in Solid Tumors
Previous Article in Journal
Cisplatin-Induced Ototoxicity in Rats Is Driven by RIP3-Dependent Necroptosis
Previous Article in Special Issue
Systematic Review of the Current Status of Human Sarcoma Cell Lines
Open AccessReview

Efficacy of Recombinant Methioninase (rMETase) on Recalcitrant Cancer Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models: A Review

1
AntiCancer, Inc., San Diego, CA 92111, USA
2
Department of Surgery, University of California, San Diego, CA 92093, USA
3
Department of Surgery, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 9808575, Japan
*
Author to whom correspondence should be addressed.
Cells 2019, 8(5), 410; https://doi.org/10.3390/cells8050410
Received: 2 April 2019 / Revised: 13 April 2019 / Accepted: 17 April 2019 / Published: 2 May 2019
An excessive requirement for methionine (MET), termed MET dependence, appears to be a general metabolic defect in cancer and has been shown to be a very effective therapeutic target. MET restriction (MR) has inhibited the growth of all major cancer types by selectively arresting cancer cells in the late-S/G2 phase, when they also become highly sensitive to cytotoxic agents. Recombinant methioninase (rMETase) has been developed to effect MR. The present review describes the efficacy of rMETase on patient-derived orthotopic xenograft (PDOX) models of recalcitrant cancer, including the surprising result that rMETase administrated orally can be highly effective. View Full-Text
Keywords: recombinant methioninase; methionine dependence; nude mice; orthotopic implantation; patient-derived tumor recombinant methioninase; methionine dependence; nude mice; orthotopic implantation; patient-derived tumor
Show Figures

Figure 1

MDPI and ACS Style

Kawaguchi, K.; Han, Q.; Li, S.; Tan, Y.; Igarashi, K.; Murakami, T.; Unno, M.; Hoffman, R.M. Efficacy of Recombinant Methioninase (rMETase) on Recalcitrant Cancer Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models: A Review. Cells 2019, 8, 410. https://doi.org/10.3390/cells8050410

AMA Style

Kawaguchi K, Han Q, Li S, Tan Y, Igarashi K, Murakami T, Unno M, Hoffman RM. Efficacy of Recombinant Methioninase (rMETase) on Recalcitrant Cancer Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models: A Review. Cells. 2019; 8(5):410. https://doi.org/10.3390/cells8050410

Chicago/Turabian Style

Kawaguchi, Kei; Han, Qinghong; Li, Shukuan; Tan, Yuying; Igarashi, Kentaro; Murakami, Takashi; Unno, Michiaki; Hoffman, Robert M. 2019. "Efficacy of Recombinant Methioninase (rMETase) on Recalcitrant Cancer Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models: A Review" Cells 8, no. 5: 410. https://doi.org/10.3390/cells8050410

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop